NEW YORK (GenomeWeb) – As diagnostic exome sequencing becomes more common for rare disorders, groups are starting to look at ways to boost the success rate of such tests, which has been hovering at around 25 percent. Many have turned to so-called 'medical exomes,' where coverage of disease-related genes is boosted.
Baylor Aims to Boost Dx Rate, Discovery with 'Medical Exome,' Consenting Unsolved Cases for Research
Premium
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.